Sahar Elahi1, Alvin H Bachman1, Sang Han Lee1, John J Sidtis2, Babak A Ardekani2. 1. The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA. 2. The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA Department of Psychiatry, New York University School of Medicine, New York, NY, USA.
Abstract
BACKGROUND: Corpus callosum (CC) size and shape have been previously studied in Alzheimer's disease (AD) with the majority of studies having been cross-sectional. Due to the large variance in normal CC morphology, cross-sectional studies are limited in statistical power. Determining individual rates of change requires longitudinal data. Physiological changes are particularly relevant in mild cognitive impairment (MCI), in which CC morphology has not been previously studied longitudinally. OBJECTIVE: To study temporal rates of change in CC morphology in MCI patients over a one-year period, and to determine whether these rates differ between MCI subjects who converted to AD (MCI-C) and those who did not (MCI-NC) over an average (±SD) observation period of 5.4 (±1.6) years. METHODS: We used a novel multi-atlas based algorithm to segment the mid-sagittal cross-sectional area of the CC in longitudinal MRI scans. Rates of change of CC circularity, total area, and five sub-areas were compared between 57 MCI-NC and 81 MCI-C subjects. RESULTS: The CC became less circular (-0.89% per year in MCI-NC, -1.85% per year in MCI-C) with time, with faster decline in MCI-C (p = 0.0002). In females, atrophy rates were higher in MCI-C relative to MCI-NC in total CC area (p = 0.0006), genu/rostrum (p = 0.005), and splenium (0.002). In males, these rates did not differ between groups. CONCLUSION: A greater than normal decline in CC circularity was shown to be an indicator of prodromal AD in MCI subjects. This measure is potentially useful as an imaging biomarker of disease and a therapeutic target in clinical trials.
BACKGROUND: Corpus callosum (CC) size and shape have been previously studied in Alzheimer's disease (AD) with the majority of studies having been cross-sectional. Due to the large variance in normal CC morphology, cross-sectional studies are limited in statistical power. Determining individual rates of change requires longitudinal data. Physiological changes are particularly relevant in mild cognitive impairment (MCI), in which CC morphology has not been previously studied longitudinally. OBJECTIVE: To study temporal rates of change in CC morphology in MCI patients over a one-year period, and to determine whether these rates differ between MCI subjects who converted to AD (MCI-C) and those who did not (MCI-NC) over an average (±SD) observation period of 5.4 (±1.6) years. METHODS: We used a novel multi-atlas based algorithm to segment the mid-sagittal cross-sectional area of the CC in longitudinal MRI scans. Rates of change of CC circularity, total area, and five sub-areas were compared between 57 MCI-NC and 81 MCI-C subjects. RESULTS: The CC became less circular (-0.89% per year in MCI-NC, -1.85% per year in MCI-C) with time, with faster decline in MCI-C (p = 0.0002). In females, atrophy rates were higher in MCI-C relative to MCI-NC in total CC area (p = 0.0006), genu/rostrum (p = 0.005), and splenium (0.002). In males, these rates did not differ between groups. CONCLUSION: A greater than normal decline in CC circularity was shown to be an indicator of prodromal AD in MCI subjects. This measure is potentially useful as an imaging biomarker of disease and a therapeutic target in clinical trials.
Entities:
Keywords:
Alzheimer's disease; brain; circularity; corpus callosum; magnetic resonance imaging; mild cognitive impairment; shape analysis
Authors: M Di Paola; F Di Iulio; A Cherubini; C Blundo; A R Casini; G Sancesario; D Passafiume; C Caltagirone; G Spalletta Journal: Neurology Date: 2010-04-06 Impact factor: 9.910
Authors: C Ryberg; E Rostrup; O B Paulson; F Barkhof; P Scheltens; E C W van Straaten; W M van der Flier; F Fazekas; R Schmidt; J M Ferro; H Baezner; T Erkinjuntti; H Jokinen; L-O Wahlund; A Poggesi; L Pantoni; D Inzitari; G Waldemar Journal: J Neurol Sci Date: 2011-05-31 Impact factor: 3.181
Authors: A Hensel; H Wolf; F Kruggel; S G Riedel-Heller; C Nikolaus; T Arendt; H J Gertz Journal: J Neurol Neurosurg Psychiatry Date: 2002-07 Impact factor: 10.154
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2017-03-22 Impact factor: 21.566
Authors: Sheelakumari Raghavan; Scott A Przybelski; Robert I Reid; Jonathan Graff-Radford; Timothy G Lesnick; Samantha M Zuk; David S Knopman; Mary M Machulda; Michelle M Mielke; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri Journal: Neurobiol Aging Date: 2020-09-08 Impact factor: 4.673
Authors: Dirk Jan Ardesch; Lianne H Scholtens; Siemon C de Lange; Lea Roumazeilles; Alexandre A Khrapitchev; Todd M Preuss; James K Rilling; Rogier B Mars; Martijn P van den Heuvel Journal: Cereb Cortex Date: 2022-06-16 Impact factor: 4.861